• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Announcements



Filters [Clear]
  • Price Sensitive: Yes
CZD Calzada to Divest MetabolicPRICE SENSITIVE21/11/14 download Created with Sketch. 60.65KB
CZD Appointment of Chief Executive OfficerPRICE SENSITIVE13/11/14 download Created with Sketch. 68.38KB
CZD US Regulatory UpdatePRICE SENSITIVE23/10/14 download Created with Sketch. 108.63KB
CZD Full Year Statutory AccountsPRICE SENSITIVE25/08/14 download Created with Sketch. 1.12MB
CZD Financial Result GuidancePRICE SENSITIVE06/08/14 download Created with Sketch. 122.29KB
CZD Calzada Update on Metabolic PharmaceuticalsPRICE SENSITIVE31/07/14 download Created with Sketch. 113.58KB
CZD PolyNovo Receives CE Mark Approval for NovoPorePRICE SENSITIVE21/07/14 download Created with Sketch. 97.42KB
CZD Significant Organisational Structure InitiativesPRICE SENSITIVE15/07/14 download Created with Sketch. 140.85KB
CZDResponse to ASX QueryPRICE SENSITIVE04/03/14 download Created with Sketch. 167.15KB
CZDHalf Yearly Report and AccountsPRICE SENSITIVE24/02/14 download Created with Sketch. 560.31KB
CZDHalf Year Financial Result GuidancePRICE SENSITIVE13/02/14 download Created with Sketch. 137.57KB
CZDRAH Surgeons Receive Approval to use BTMPRICE SENSITIVE04/02/14 download Created with Sketch. 200.12KB
CZDMetabolic Licenses AOD9604PRICE SENSITIVE28/01/14 download Created with Sketch. 144.93KB
CZDNovoSorb BTM Burn TrialPRICE SENSITIVE23/12/13 download Created with Sketch. 55.63KB
CZDSuccessful Clinical Trial Outcomes for NovoSorb BTMPRICE SENSITIVE10/10/13 download Created with Sketch. 165KB
CZDResponse to ASX Price and Volume QueryPRICE SENSITIVE11/09/13 download Created with Sketch. 161.07KB
CZDFull Year Statutory AccountsPRICE SENSITIVE28/08/13 download Created with Sketch. 1.48MB
CZDFinancial Result GuidancePRICE SENSITIVE16/08/13 download Created with Sketch. 61.92KB
CZDResponse to Media SpeculationPRICE SENSITIVE29/07/13 download Created with Sketch. 124.05KB
CZDTrading halt and requestPRICE SENSITIVE29/07/13 download Created with Sketch. 150.06KB
CZDFinal Patient Treated in NovoSorb BTM Clinical TrialPRICE SENSITIVE26/07/13 download Created with Sketch. 119.29KB
CZDNovoSorb Hernia Repair Feasibility AgreementPRICE SENSITIVE17/07/13 download Created with Sketch. 131.49KB
CZDPolyNovo Partners in the Field of Aesthetic Facial SurgeryPRICE SENSITIVE09/07/13 download Created with Sketch. 209.91KB
CZDShare Purchase PlanPRICE SENSITIVE19/06/13 download Created with Sketch. 1.38MB
CZDPlacement and Share Purchase PlanPRICE SENSITIVE12/06/13 download Created with Sketch. 135.28KB
CZDTrading HaltPRICE SENSITIVE07/06/13 download Created with Sketch. 72.34KB
CZDAOD9604 Important ClarificationsPRICE SENSITIVE26/04/13 download Created with Sketch. 182.04KB
CZDPositive Results from NovoSorb Human Clinical TrialPRICE SENSITIVE17/04/13 download Created with Sketch. 309.95KB
CZDTopical Negative Pressure Human Trial CompletedPRICE SENSITIVE28/03/13 download Created with Sketch. 121.98KB
CZDHalf Yearly Report and AccountsPRICE SENSITIVE25/02/13 download Created with Sketch. 875.54KB
CZDUS BARDA Contract Application and BTM Trial UpdatePRICE SENSITIVE18/02/13 download Created with Sketch. 331.87KB
CZDHalf Year Financial Result GuidancePRICE SENSITIVE15/02/13 download Created with Sketch. 123.33KB
CZDAOD9604 Positive in Osteoarthritis Animal ModelPRICE SENSITIVE05/02/13 download Created with Sketch. 193.85KB
CZDPolyNovo Concludes Recruitment for VAC TrialPRICE SENSITIVE04/02/13 download Created with Sketch. 166.47KB
CZDR and D Tax Refund ReceivedPRICE SENSITIVE30/01/13 download Created with Sketch. 106.88KB
CZDAdditional PolyNovo US Patent AllowedPRICE SENSITIVE18/10/12 download Created with Sketch. 117.61KB
CZDNovoSorb BTM Proof of Concept in Man AchievedPRICE SENSITIVE15/10/12 download Created with Sketch. 608.85KB
CZDPolyNovo Clinical Trials UpdatePRICE SENSITIVE11/09/12 download Created with Sketch. 159.99KB
CZDAppendix 4E and 2012 Annual ReportPRICE SENSITIVE24/08/12 download Created with Sketch. 1.66MB
CZDPolyNovo Clinical Trials UpdatePRICE SENSITIVE24/08/12 download Created with Sketch. 152.89KB
CZDPolyNovo US Patent AllowedPRICE SENSITIVE07/08/12 download Created with Sketch. 139.55KB
CZDVAC Human Clinical Trial UpdatePRICE SENSITIVE30/07/12 download Created with Sketch. 137.13KB
CZDAOD9604 Receives GRAS StatusPRICE SENSITIVE25/06/12 download Created with Sketch. 177.82KB
CZDPolyNovo Commences Second Human TrialPRICE SENSITIVE03/04/12 download Created with Sketch. 58.98KB
CZDPolyNovo Human Trial UpdatePRICE SENSITIVE19/03/12 download Created with Sketch. 134.34KB
CZDAOD9604 Positive in Cartilage and Muscle RepairPRICE SENSITIVE13/03/12 download Created with Sketch. 46.03KB
CZDHalf Yearly Report and AccountsPRICE SENSITIVE23/02/12 download Created with Sketch. 877.83KB
CZDHalf Year Financial Result GuidancePRICE SENSITIVE15/02/12 download Created with Sketch. 136.58KB
CZDMetabolic Commences Seeking Partners for Bone ApplicationsPRICE SENSITIVE13/02/12 download Created with Sketch. 147.63KB
CZDPolynovo to Commence First Human TrialPRICE SENSITIVE06/02/12 download Created with Sketch. 188.83KB
CZDPolyNovo US Collaboration UpdatePRICE SENSITIVE01/02/12 download Created with Sketch. 142.98KB
CZDUpdate on US Partner CollaborationPRICE SENSITIVE04/01/12 download Created with Sketch. 40.46KB
CZDPolynovo UpdatePRICE SENSITIVE22/12/11 download Created with Sketch. 49.99KB
CZDNew Applications for AOD9604PRICE SENSITIVE14/12/11 download Created with Sketch. 182.03KB
CZDSuccessful Proof of Concept for Synthetic SkinPRICE SENSITIVE17/10/11 download Created with Sketch. 1.12MB
CZDChanges to Executive StructurePRICE SENSITIVE07/10/11 download Created with Sketch. 153.63KB
CZDBTM safety studies updatePRICE SENSITIVE06/10/11 download Created with Sketch. 138.37KB
CZDAppendix 4E and 2011 Annual ReportPRICE SENSITIVE26/08/11 download Created with Sketch. 1.88MB
CZDOperational Update and Financial Result GuidancePRICE SENSITIVE11/08/11 download Created with Sketch. 193.15KB
CZDFirst Human Study for PolyNovos NovosorbPRICE SENSITIVE04/07/11 download Created with Sketch. 123.56KB
CZDMetabolic's Osteoporosis Patent Allowed in USPRICE SENSITIVE20/05/11 download Created with Sketch. 144.34KB
CZDResponse to ASX QueryPRICE SENSITIVE13/05/11 download Created with Sketch. 65.87KB
CZDCalzada Transfers Neural Regeneration Peptides TechnologyPRICE SENSITIVE13/04/11 download Created with Sketch. 139.2KB
CZDPOH: Phosphagenics to launch new cellulite cosmeticsPRICE SENSITIVE11/04/11 download Created with Sketch. 74.92KB
CZDFirst PolyNovo Patent Allowed in USPRICE SENSITIVE04/04/11 download Created with Sketch. 121.04KB
CZDPolynovo Completes Pivotal Study on BurnsPRICE SENSITIVE03/03/11 download Created with Sketch. 210.58KB
CZDAOD9604 Positive in Human Bone GrowthPRICE SENSITIVE10/02/11 download Created with Sketch. 200.47KB
CZDFeasibility Study Extended by 12 MonthsPRICE SENSITIVE06/01/11 download Created with Sketch. 73.18KB
CZDUpdate of Black Market Sales of AOD9604PRICE SENSITIVE01/12/10 download Created with Sketch. 65.95KB
CZDDr Stewart Washer joins Calzada as CEOPRICE SENSITIVE23/11/10 download Created with Sketch. 105.13KB
AVX +Calzada sells Avexa SharesPRICE SENSITIVE20/10/10 download Created with Sketch. 56.45KB
CZD +Anti-fat Peptide Patch progresses - product sales early 2011PRICE SENSITIVE19/10/10 download Created with Sketch. 54.61KB
CZD +Calzada signs Licensing deal with PhosphagenicsPRICE SENSITIVE19/10/10 download Created with Sketch. 64.96KB
ATW +Termination of Metabolic vend-in proposalPRICE SENSITIVE21/09/10 download Created with Sketch. 35.09KB
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604PRICE SENSITIVE02/09/10 download Created with Sketch. 61.22KB
CZD +Phosphagenics - Calzada - Exercise of optionPRICE SENSITIVE02/09/10 download Created with Sketch. 61.06KB
CZDPreliminary Final ReportPRICE SENSITIVE31/08/10 download Created with Sketch. 233.56KB
ATW +Calzada to vend Metabolic into ATOS WellnessPRICE SENSITIVE30/07/10 download Created with Sketch. 79.18KB
CZD +Xceed sells Calzada holdingPRICE SENSITIVE22/06/10 download Created with Sketch. 66.61KB
CZDNovoSkin awarded BioInnovationSA GrantPRICE SENSITIVE17/06/10 download Created with Sketch. 54.38KB
CZDBiomet and PolyNovo mutually terminate Development and LicenPRICE SENSITIVE11/06/10 download Created with Sketch. 34.47KB
CZDHalf Year Report and AccountsPRICE SENSITIVE25/02/10 download Created with Sketch. 343.84KB
CZDCalzada moves to 100% ownership of PolyNovoPRICE SENSITIVE18/02/10 download Created with Sketch. 48.96KB
CZD +Calzada to Increase its Shareholding in PolyNovoPRICE SENSITIVE23/12/09 download Created with Sketch. 36.69KB
CZD Calzada to Divest Metabolic
21/11/14PRICE SENSITIVE download Created with Sketch. 60.65KB
CZD Appointment of Chief Executive Officer
13/11/14PRICE SENSITIVE download Created with Sketch. 68.38KB
CZD US Regulatory Update
23/10/14PRICE SENSITIVE download Created with Sketch. 108.63KB
CZD Full Year Statutory Accounts
25/08/14PRICE SENSITIVE download Created with Sketch. 1.12MB
CZD Financial Result Guidance
06/08/14PRICE SENSITIVE download Created with Sketch. 122.29KB
CZD Calzada Update on Metabolic Pharmaceuticals
31/07/14PRICE SENSITIVE download Created with Sketch. 113.58KB
CZD PolyNovo Receives CE Mark Approval for NovoPore
21/07/14PRICE SENSITIVE download Created with Sketch. 97.42KB
CZD Significant Organisational Structure Initiatives
15/07/14PRICE SENSITIVE download Created with Sketch. 140.85KB
CZDResponse to ASX Query
04/03/14PRICE SENSITIVE download Created with Sketch. 167.15KB
CZDHalf Yearly Report and Accounts
24/02/14PRICE SENSITIVE download Created with Sketch. 560.31KB
CZDHalf Year Financial Result Guidance
13/02/14PRICE SENSITIVE download Created with Sketch. 137.57KB
CZDRAH Surgeons Receive Approval to use BTM
04/02/14PRICE SENSITIVE download Created with Sketch. 200.12KB
CZDMetabolic Licenses AOD9604
28/01/14PRICE SENSITIVE download Created with Sketch. 144.93KB
CZDNovoSorb BTM Burn Trial
23/12/13PRICE SENSITIVE download Created with Sketch. 55.63KB
CZDSuccessful Clinical Trial Outcomes for NovoSorb BTM
10/10/13PRICE SENSITIVE download Created with Sketch. 165KB
CZDResponse to ASX Price and Volume Query
11/09/13PRICE SENSITIVE download Created with Sketch. 161.07KB
CZDFull Year Statutory Accounts
28/08/13PRICE SENSITIVE download Created with Sketch. 1.48MB
CZDFinancial Result Guidance
16/08/13PRICE SENSITIVE download Created with Sketch. 61.92KB
CZDResponse to Media Speculation
29/07/13PRICE SENSITIVE download Created with Sketch. 124.05KB
CZDTrading halt and request
29/07/13PRICE SENSITIVE download Created with Sketch. 150.06KB
CZDFinal Patient Treated in NovoSorb BTM Clinical Trial
26/07/13PRICE SENSITIVE download Created with Sketch. 119.29KB
CZDNovoSorb Hernia Repair Feasibility Agreement
17/07/13PRICE SENSITIVE download Created with Sketch. 131.49KB
CZDPolyNovo Partners in the Field of Aesthetic Facial Surgery
09/07/13PRICE SENSITIVE download Created with Sketch. 209.91KB
CZDShare Purchase Plan
19/06/13PRICE SENSITIVE download Created with Sketch. 1.38MB
CZDPlacement and Share Purchase Plan
12/06/13PRICE SENSITIVE download Created with Sketch. 135.28KB
CZDTrading Halt
07/06/13PRICE SENSITIVE download Created with Sketch. 72.34KB
CZDAOD9604 Important Clarifications
26/04/13PRICE SENSITIVE download Created with Sketch. 182.04KB
CZDPositive Results from NovoSorb Human Clinical Trial
17/04/13PRICE SENSITIVE download Created with Sketch. 309.95KB
CZDTopical Negative Pressure Human Trial Completed
28/03/13PRICE SENSITIVE download Created with Sketch. 121.98KB
CZDHalf Yearly Report and Accounts
25/02/13PRICE SENSITIVE download Created with Sketch. 875.54KB
CZDUS BARDA Contract Application and BTM Trial Update
18/02/13PRICE SENSITIVE download Created with Sketch. 331.87KB
CZDHalf Year Financial Result Guidance
15/02/13PRICE SENSITIVE download Created with Sketch. 123.33KB
CZDAOD9604 Positive in Osteoarthritis Animal Model
05/02/13PRICE SENSITIVE download Created with Sketch. 193.85KB
CZDPolyNovo Concludes Recruitment for VAC Trial
04/02/13PRICE SENSITIVE download Created with Sketch. 166.47KB
CZDR and D Tax Refund Received
30/01/13PRICE SENSITIVE download Created with Sketch. 106.88KB
CZDAdditional PolyNovo US Patent Allowed
18/10/12PRICE SENSITIVE download Created with Sketch. 117.61KB
CZDNovoSorb BTM Proof of Concept in Man Achieved
15/10/12PRICE SENSITIVE download Created with Sketch. 608.85KB
CZDPolyNovo Clinical Trials Update
11/09/12PRICE SENSITIVE download Created with Sketch. 159.99KB
CZDAppendix 4E and 2012 Annual Report
24/08/12PRICE SENSITIVE download Created with Sketch. 1.66MB
CZDPolyNovo Clinical Trials Update
24/08/12PRICE SENSITIVE download Created with Sketch. 152.89KB
CZDPolyNovo US Patent Allowed
07/08/12PRICE SENSITIVE download Created with Sketch. 139.55KB
CZDVAC Human Clinical Trial Update
30/07/12PRICE SENSITIVE download Created with Sketch. 137.13KB
CZDAOD9604 Receives GRAS Status
25/06/12PRICE SENSITIVE download Created with Sketch. 177.82KB
CZDPolyNovo Commences Second Human Trial
03/04/12PRICE SENSITIVE download Created with Sketch. 58.98KB
CZDPolyNovo Human Trial Update
19/03/12PRICE SENSITIVE download Created with Sketch. 134.34KB
CZDAOD9604 Positive in Cartilage and Muscle Repair
13/03/12PRICE SENSITIVE download Created with Sketch. 46.03KB
CZDHalf Yearly Report and Accounts
23/02/12PRICE SENSITIVE download Created with Sketch. 877.83KB
CZDHalf Year Financial Result Guidance
15/02/12PRICE SENSITIVE download Created with Sketch. 136.58KB
CZDMetabolic Commences Seeking Partners for Bone Applications
13/02/12PRICE SENSITIVE download Created with Sketch. 147.63KB
CZDPolynovo to Commence First Human Trial
06/02/12PRICE SENSITIVE download Created with Sketch. 188.83KB
CZDPolyNovo US Collaboration Update
01/02/12PRICE SENSITIVE download Created with Sketch. 142.98KB
CZDUpdate on US Partner Collaboration
04/01/12PRICE SENSITIVE download Created with Sketch. 40.46KB
CZDPolynovo Update
22/12/11PRICE SENSITIVE download Created with Sketch. 49.99KB
CZDNew Applications for AOD9604
14/12/11PRICE SENSITIVE download Created with Sketch. 182.03KB
CZDSuccessful Proof of Concept for Synthetic Skin
17/10/11PRICE SENSITIVE download Created with Sketch. 1.12MB
CZDChanges to Executive Structure
07/10/11PRICE SENSITIVE download Created with Sketch. 153.63KB
CZDBTM safety studies update
06/10/11PRICE SENSITIVE download Created with Sketch. 138.37KB
CZDAppendix 4E and 2011 Annual Report
26/08/11PRICE SENSITIVE download Created with Sketch. 1.88MB
CZDOperational Update and Financial Result Guidance
11/08/11PRICE SENSITIVE download Created with Sketch. 193.15KB
CZDFirst Human Study for PolyNovos Novosorb
04/07/11PRICE SENSITIVE download Created with Sketch. 123.56KB
CZDMetabolic's Osteoporosis Patent Allowed in US
20/05/11PRICE SENSITIVE download Created with Sketch. 144.34KB
CZDResponse to ASX Query
13/05/11PRICE SENSITIVE download Created with Sketch. 65.87KB
CZDCalzada Transfers Neural Regeneration Peptides Technology
13/04/11PRICE SENSITIVE download Created with Sketch. 139.2KB
CZDPOH: Phosphagenics to launch new cellulite cosmetics
11/04/11PRICE SENSITIVE download Created with Sketch. 74.92KB
CZDFirst PolyNovo Patent Allowed in US
04/04/11PRICE SENSITIVE download Created with Sketch. 121.04KB
CZDPolynovo Completes Pivotal Study on Burns
03/03/11PRICE SENSITIVE download Created with Sketch. 210.58KB
CZDAOD9604 Positive in Human Bone Growth
10/02/11PRICE SENSITIVE download Created with Sketch. 200.47KB
CZDFeasibility Study Extended by 12 Months
06/01/11PRICE SENSITIVE download Created with Sketch. 73.18KB
CZDUpdate of Black Market Sales of AOD9604
01/12/10PRICE SENSITIVE download Created with Sketch. 65.95KB
CZDDr Stewart Washer joins Calzada as CEO
23/11/10PRICE SENSITIVE download Created with Sketch. 105.13KB
AVX +Calzada sells Avexa Shares
20/10/10PRICE SENSITIVE download Created with Sketch. 56.45KB
CZD +Anti-fat Peptide Patch progresses - product sales early 2011
19/10/10PRICE SENSITIVE download Created with Sketch. 54.61KB
CZD +Calzada signs Licensing deal with Phosphagenics
19/10/10PRICE SENSITIVE download Created with Sketch. 64.96KB
ATW +Termination of Metabolic vend-in proposal
21/09/10PRICE SENSITIVE download Created with Sketch. 35.09KB
CZD +PHOSPHAGENICS EXERCISES OPTION TO LICENCE AOD9604
02/09/10PRICE SENSITIVE download Created with Sketch. 61.22KB
CZD +Phosphagenics - Calzada - Exercise of option
02/09/10PRICE SENSITIVE download Created with Sketch. 61.06KB
CZDPreliminary Final Report
31/08/10PRICE SENSITIVE download Created with Sketch. 233.56KB
ATW +Calzada to vend Metabolic into ATOS Wellness
30/07/10PRICE SENSITIVE download Created with Sketch. 79.18KB
CZD +Xceed sells Calzada holding
22/06/10PRICE SENSITIVE download Created with Sketch. 66.61KB
CZDNovoSkin awarded BioInnovationSA Grant
17/06/10PRICE SENSITIVE download Created with Sketch. 54.38KB
CZDBiomet and PolyNovo mutually terminate Development and Licen
11/06/10PRICE SENSITIVE download Created with Sketch. 34.47KB
CZDHalf Year Report and Accounts
25/02/10PRICE SENSITIVE download Created with Sketch. 343.84KB
CZDCalzada moves to 100% ownership of PolyNovo
18/02/10PRICE SENSITIVE download Created with Sketch. 48.96KB
CZD +Calzada to Increase its Shareholding in PolyNovo
23/12/09PRICE SENSITIVE download Created with Sketch. 36.69KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.